Yahoo
NYSE - Delayed Quote USD

AstraZeneca PLC (AZN)

162.70 -2.07 (-1.26%)
At close: September 4 at 4:00:02 PM EDT
164.53 +1.83 (+1.12%)
After hours: September 4 at 7:57:12 PM EDT
Trade AZN on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
61,366,000
58,739,000
54,073,000
45,811,000
44,351,000
Cost of Revenue
11,120,000
10,633,000
10,207,000
8,268,000
12,391,000
Gross Profit
50,246,000
48,106,000
43,866,000
37,543,000
31,960,000
Operating Expense
36,691,000
34,779,000
33,615,000
28,821,000
27,448,000
Operating Income
13,555,000
13,327,000
10,251,000
8,722,000
4,512,000
Net Non Operating Interest Income Expense
-1,293,000
-1,254,000
-1,337,000
-1,288,000
-1,249,000
Pretax Income
12,586,000
12,402,000
8,691,000
6,899,000
2,501,000
Tax Provision
2,133,000
2,169,000
1,650,000
938,000
-792,000
Net Income Common Stockholders
10,446,000
10,225,000
7,035,000
5,955,000
3,288,000
Diluted NI Available to Com Stockholders
10,446,000
10,225,000
7,035,000
5,955,000
3,288,000
Basic EPS
6.74
6.60
4.54
3.84
2.12
Diluted EPS
6.68
6.54
4.50
3.81
2.11
Basic Average Shares
1,550,000
1,550,000
1,550,000
1,549,000
1,548,000
Diluted Average Shares
1,562,500
1,562,000
1,563,000
1,562,000
1,560,000
Total Operating Income as Reported
13,971,000
13,743,000
10,003,000
8,193,000
3,757,000
Rent Expense Supplemental
--
452,000
377,000
301,000
268,000
Total Expenses
47,811,000
45,412,000
43,822,000
37,089,000
39,839,000
Net Income from Continuing & Discontinued Operation
10,446,000
10,225,000
7,035,000
5,955,000
3,288,000
Normalized Income
10,141,196.96
9,924,060
7,158,952.71
6,377,514.71
3,888,210
Interest Income
364,000
360,000
345,000
301,000
81,000
Interest Expense
1,657,000
1,614,000
1,682,000
1,589,000
1,330,000
Net Interest Income
-1,293,000
-1,254,000
-1,337,000
-1,288,000
-1,249,000
EBIT
14,243,000
14,016,000
10,373,000
8,488,000
3,831,000
EBITDA
20,355,000
19,506,000
15,438,000
13,422,000
9,085,000
Reconciled Cost of Revenue
11,120,000
10,633,000
10,207,000
8,268,000
12,391,000
Reconciled Depreciation
6,112,000
5,490,000
5,065,000
4,934,000
5,254,000
Net Income from Continuing Operation Net Minority Interest
10,446,000
10,225,000
7,035,000
5,955,000
3,288,000
Total Unusual Items Excluding Goodwill
367,000
367,000
-153,000
-489,000
-741,000
Total Unusual Items
367,000
367,000
-153,000
-489,000
-741,000
Normalized EBITDA
19,988,000
19,139,000
15,591,000
13,911,000
9,826,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
62,196.96
66,060
-29,047.29
-66,485.29
-140,790
12/31/2022 - 5/12/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: